Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.
Press releases published on June 25, 2025
Acceleware Announces RF XL 2.0
GlobeNewswire
·
June 25, 2025
CALGARY, Alberta, June 25, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine …
Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26
GlobeNewswire
·
June 25, 2025
GAITHERSBURG, Md., June 25, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, will host an investor webcast on …
Rakovina Therapeutics Announces Results from 2025 Annual General Meeting
GlobeNewswire
·
June 25, 2025
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)- …
ZOCCAM, U.S. Bank and Stewart Title launch solution for faster, more secure title payments with Request for Payment
EIN Presswire
·
June 25, 2025
DALLAS, TX, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- ZOCCAM, a leading innovator in real estate payment technology, together with U.S. Bank and Stewart Title, has facilitated the first Request for Payment use case that improves the home buying …
ABeam Consulting (USA) Ltd. and Millennium EBS Establish Strategic Collaborations to Expedite ISO 20022 Implementation
GlobeNewswire
·
June 25, 2025
LOS ANGELES, June 25, 2025 (GLOBE NEWSWIRE) -- ABeam Consulting (USA) Ltd. (“ABeam US”) and Millennium EBS, a BlueOne Card Inc. subsidiary, have announced a strategic collaboration under a newly signed Master Services Agreement (MSA) to jointly promote the …
PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares
GlobeNewswire
·
June 25, 2025
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its …
Clip Money Inc. Announces Results of Voting at Annual Meeting of Shareholders
GlobeNewswire
·
June 25, 2025
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (OTCQB: CLPMF) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce the results of voting at its …
Vor Bio Announces $175 Million Private Placement
GlobeNewswire
·
June 25, 2025
CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it has entered into a securities purchase agreement for a private …
Data Squared (Data²) Secures Patent for Hallucination-Resistant, Explainable AI Systems
GlobeNewswire
·
June 25, 2025
BELLEVUE, Wash., June 25, 2025 (GLOBE NEWSWIRE) -- Data Squared (Data²), a Service-Disabled Veteran-Owned Small Business dedicated to helping public and private sector organizations unlock the full potential of their data, today announced that the U.S. …
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
GlobeNewswire
·
June 25, 2025
-Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis -RemeGen receives initial payment of $125 million …
Main Results of 2025 Annual and Extraordinary General Meeting
GlobeNewswire
·
June 25, 2025
REYKJAVÍK, Iceland and LUXEMBOURG, June 25, 2025 (GLOBE NEWSWIRE) -- The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg, …
BIGtoken Welcomes Pro Soccer and Sports Industry Leaders Aly Wagner and Adam Eyre as Strategic Investors and Advisors
GlobeNewswire
·
June 25, 2025
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- BIGtoken, the Web3 marketing platform helping organizations turn real-world audiences into owned, monetizable data, today announced a strategic partnership with soccer industry veterans Aly Wagner and Adam Eyre. …
Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025
GlobeNewswire
·
June 25, 2025
TEL AVIV, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2025 financial results on Wednesday, July 30, 2025, at 7:00 a.m. ET. …
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
GlobeNewswire
·
June 25, 2025
CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide.
GlobeNewswire
·
June 25, 2025
Châtillon, France, le 25 juin (22 :30 CEST) 2025 DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide. Screening du premier sujet à l' …
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
GlobeNewswire
·
June 25, 2025
Châtillon, France, June 25, 2025 DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old First subject screened at the Respiratory Medicine Research Institute of Michigan …
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET
GlobeNewswire
·
June 25, 2025
HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …
Before The Dates Introduces Scheduled Messaging and Gifting App to Support Relationship Consistency
GlobeNewswire
·
June 25, 2025
Before The Dates Logo ORLANDO, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- The team behind Before The Dates has announced the launch of a new time texting app designed to help users maintain consistency in their personal and professional relationships. The app …
Kymera Therapeutics Announces Proposed Public Offering
GlobeNewswire
·
June 25, 2025
WATERTOWN, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that it has …
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
GlobeNewswire
·
June 25, 2025
IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that it will host an R…